Uveitis: Clinical Trials

6 trials for Uveitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Terminated 6
Phase 25Terminated 5

Follow Uveitis: new trials by email Literature Review of Uveitis trials Research Report on Uveitis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants
REGN7041 - Active Noninfectious Uveitis Affecting the Posterior Segment
Phase 1 / Phase 2TerminatedRegeneron Pharmaceuticals12025-12-172026-08-17
Safety and Preliminary Efficacy Study of V404 PDS in Uveitis
V404 - Uveitis, Posterior, Uveitis, Intermediate
Phase 1 / Phase 2TerminatedForsight Vision472014-04-012016-12-09
Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate
Methotrexate - Non-infectious Intermediate and Posterior Uveitis
Phase 1 / Phase 2TerminatedNational Eye Institute (NEI)22011-02-012019-03-27
Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema
Microplasmin - Uveitis
Phase 1 / Phase 2TerminatedNational Institutes of Health Clinical Center (CC)22011-01-012018-07-31
Apremilast in the Treatment of Uveitis
Apremilast - Uveitis
Phase 1 / Phase 2TerminatedOregon Health and Science University32009-11-012014-07-08
Stem Cell Transplantation in Ocular Lesions of Behcet's Disease
Autologous Stem Cell Transplantation - Retinitis, Behcet's Syndrome
Phase 1TerminatedTehran University of Medical Sciences52007-12-012015-11-10

Narrower conditions

Macular Edema (2)  ·  Uveitis, Posterior (2)  ·  Behcet Syndrome (1)  ·  Panuveitis (1)  ·  Papilledema (1)  ·  Retinal Vasculitis (1)  ·  Retinitis (1)  ·  Uveitis, Intermediate (1)

Broader conditions

Eye Diseases (6)  ·  Uveal Diseases (6)  ·  Panuveitis (3)  ·  Retinal Diseases (3)  ·  Macular Degeneration (2)  ·  Retinal Degeneration (2)  ·  Cardiovascular Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Cranial Nerve Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Hereditary Autoinflammatory Diseases (1)  ·  Mouth Diseases (1)  ·  Nervous System Diseases (1)  ·  Optic Nerve Diseases (1)

Interventions

Methotrexate (2)  ·  apremilast (1)  ·  microplasmin (1)

Sponsors

Forsight Vision4 (1)  ·  National Eye Institute (NEI) (1)  ·  National Institutes of Health Clinical Center (CC) (1)  ·  Oregon Health and Science University (1)  ·  Regeneron Pharmaceuticals (1)  ·  Tehran University of Medical Sciences (1)

Countries

United States (5)  ·  Iran (1)

Top investigators

Behrouz Nikbin, MD (1)  ·  Eric B Suhler, MD, MPH (1)  ·  Fereydoun Davatchi, MD (1)  ·  Hatice N Sen, M.D. (1)  ·  Hatice Nida Sen, MD, MHSc (1)  ·  Hormoz Shams, MD (1)

Results publications

PMID 23773637

NIH funding

2025 (1)